AzTrials
AzTrials

Non-Prescription Drug MisuseNCT06317415

Intervention on Non-prescription Antibiotic Use Among the Public

A study testing WeChat-based health education on antibiotic use and Regular public health education in people with Non-Prescription Drug Misuse and Antibiotic Use, run by Huazhong University of Science and Technology at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to test the effectiveness of health education int led by community health workers for non-prescription antibiotic use among the public. In this two arm cluster randomised trial, In this two-arm cluster randomized controlled trial, 22 communities were randomly allocated in a 1:1 ratio to… Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Non-Prescription Drug Misuse, Antibiotic Use
What is being tested?
WeChat-based health education on antibiotic use and Regular public health education
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
1,550 participants
Where
1 siteChina
Study dates
1 Apr 2023to 1 Mar 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Aged between 18 and 75 years old;
  • Local residents (residing for more than 6 months) with no plans for employment, study, or relocation in the next six months;
  • Having normal cognitive, comprehension, and independent communication abilities, and voluntarily participating in this study;
  • Able to use WeChat independently or with guidance from family members.

Who cannot join

  • Unable to comprehend the purpose of the survey, unwilling to cooperate, or lacking willingness to provide honest answers to questions;
  • Illiterate, severely physically disabled, or lacking necessary comprehension abilities;
  • Healthcare professionals, such as doctors, nurses, pharmacists, etc.;
  • Individuals with autoimmune diseases or hereditary diseases affecting the use of common medications;

Trial locations and contacts

1 site in 1 country.

China1 site
  • Fuyong People's Hospital

    Shenzhen, Guangdong, 518103

Other trials in China

About this study

Official title: Effect of Health Education on Non-prescription Antibiotic Use Among the Public: a Cluster Randomized Controlled Trial

The purpose of this study is to test the effectiveness of health education int led by community health workers for non-prescription antibiotic use among the public. In this two arm cluster randomised trial, In this two-arm cluster randomized controlled trial, 22 communities were randomly allocated in a 1:1 ratio to intervention and control groups. In the intervention group, family doctors will conduct WeChat-based health education on responsible use of antibiotic for the participants. In the control group, only routine public health education will be provided without any involvement in antibiotic use. The primary outcome is the incidence of antibiotic use without prescription in the past month.

Being tested
WeChat-based health education on antibiotic use, Regular public health education
Keywords
Cluster randomized trial, Non-prescription, antibiotic
Medical subject headings
Drug Misuse

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • WeChat-based health education on antibiotic useBehavioural

    Health education based on the WeChat platform includes popular science articles on WeChat public Platform and health education videos.

  • Regular public health educationBehavioural

    Health education information on the prevention and control of common chronic diseases

Study groups in NCT06317415
Study groupRoleWhat they receive
Intervention groupExperimentalNot described
Receives: Behavioral: WeChat-based health education on antibiotic use
control groupPlacebo comparatorNot described
Receives: Behavioral: Regular public health education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of non-prescription antibiotic use among the public

    Rate of Antibiotic use without prescription in the past month measured by self-designed questionnaire。

    Measured: within one month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Mar 2024
  2. Study start1 Apr 2023
  3. Primary completion31 Dec 2023
  4. Study completion1 Mar 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
1,550 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06317415
Sponsor's protocol ID
HuazhongU20240312
Status last verified
Mar 2024
First submitted
12 Mar 2024
Last updated
20 Mar 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing WeChat-based health education on antibiotic use and Regular public health education in people with Non-Prescription Drug Misuse and Antibiotic Use, run by Huazhong University of Science and Technology at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of non-prescription antibiotic use among the public (time frame: within one month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in